logo
Systematic review: fertility in non-surgically treated inflammatory bowel disease
Systematic review: the efficacy of herbal therapy in inflammatory bowel disease
Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide
Review article: autoimmune hepatitis – current management and challenges
Review article: biosimilars are the next generation of drugs for liver and gastrointestinal diseases
Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth
Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit
Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake
Prevalence of graft versus host disease and cytomegalovirus infection in patients post-haematopoietic cell transplantation presenting with gastrointestinal symptoms
Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention
The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation
Commentary: salvage medical therapy for acute severe colitis – ciclosporin or infliximab?
Commentary: salvage medical therapy for acute severe colitis – ciclosporin or infliximab? Author's reply
Commentary: H. pylori eradication therapy after subtotal gastrectomy for gastric cancer – can the qualitative be quantified?
Commentary: H. pylori eradication therapy after subtotal gastrectomy for gastric cancer – can the qualitative be quantified? Authors' reply
Letter: ciclosporin or infliximab in acute ulcerative colitis - still undecided
Letter: ciclosporin or infliximab in acute ulcerative colitis - still undecided; authors’ reply
Corrigendum